Suchergebnisse - "Gennari, Alessandra"

PubPharm (12)

1

Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs)

enthalten in: Cancer treatment reviews | 2024

von Dri, A. | Arpino, G. | Bianchini, G. | +12

ErratumIn: Cancer Treat Rev. 2024 Mar 16;125:102714. - PMID 38493647

2

Treatment and outcomes in breast cancer patients : A cross section study from the EUSOMA breast centre network

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Aristei, C. | Tomatis, M. | Antonio Ponti | +51

3

Essential requirements for reporting radiation therapy in breast cancer clinical trials : An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2023

von Kaidar-Person, O. | Meattini, I. | Boersma, L. | +22

4

Tucatinib's journey from clinical development to clinical practice : New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread

enthalten in: Cancer treatment reviews | 2023

von Criscitiello, C. | Corti, C. | De Laurentiis, M. | +17

5

Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer : the key role of histopathology. Evidence from an international multicentre prospective study

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Bottoni, G. | Fiz, F. | Puntoni, M. | +14

CommentOn: Mol Imaging Biol. 2014 Jun;16(3):431-40. - PMID 24170452

6

Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Bottoni, G. | Fiz, F. | Puntoni, M. | +14

7

Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study

enthalten in: European journal of nuclear medicine & molecular imaging | 2023

von Bottoni, G. | Fiz, F. | Puntoni, M. | +14

8

Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Bottoni, G. | Fiz, F. | Puntoni, M. | +14

9

Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT

enthalten in: European journal of radiology | 2021

von Bottoni, G. | Piccardo, A. | Fiz, F. | +17

10

Whither the PET Scan? The Role of PET Imaging in the Staging and Treatment of Breast Cancer

enthalten in: Current oncology reports | 2011

von Gennari, A. | Piccardo, A. | Altrinetti, V. | +3